Nima Sharifi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Benign Prostatic Hyperplasia

Endoplasmic Reticulum

Regulatory T Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature reviews. Urology

The Journal of biological chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Masoud Bitaraf, Ranjith Ramasamy, Sanoj Punnen, Nima Sharifi
Elevated periprostatic androgens, sneaky testosterone and its implications. Nature reviews. Urology (2024)
Patrick Michael, Gustavo Roversi, Kristy Brown, Nima Sharifi
Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer. Endocrinology 164 (3) (2023)
Patrick Michael, Gustavo Roversi, Kristy Brown, Nima Sharifi
Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer. Endocrinology 164 (3) (2023)
Charles S Dai, Scott M Dehm, Nima Sharifi
Targeting the Androgen Signaling Axis in Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Patrick Michael, Gustavo Roversi, Kristy Brown, Nima Sharifi
Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer. Endocrinology 164 (3) (2023)
Aimalie L Hardaway, Maryam Goodarzi, Michael Berk, Jianneng Li, Yoon-Mi Chung, Nima Sharifi
Response to "Letter to the Editor from Penning and Deltefsen "5-hydroxyeicosatetraenoic acid controls androgen reduction in diverse types of human epithelial cells". Endocrinology (2023)
Jeffrey M McManus, Yoon-Mi Chung, Nima Sharifi
3βHSD activity saturates at physiological substrate concentrations in intact cells. The Prostate (2023)
Liang Qin, Yoon-Mi Chung, Michael Berk, Bryan D Naelitz, Ziqi Zhu, Eric E Klein, Abhishek A Chakraborty, Nima Sharifi
Hypoxia-Reoxygenation Couples 3βHSD1 Enzyme and Cofactor Upregulation to Facilitate Androgen Biosynthesis and Hormone Therapy Resistance in Prostate Cancer. Cancer research 82 (13) (2022)
Patrick Michael, Gustavo Roversi, Kristy Brown, Nima Sharifi
Adrenal steroids and resistance to hormonal blockade of prostate and breast cancer. Endocrinology (2022)
Mehdi Baratchian, Ritika Tiwari, Sirvan Khalighi, Ankur Chakravarthy, Wei Yuan, Michael Berk, Jianneng Li, Amy Guerinot, Johann de Bono, Vladimir Makarov, Timothy A Chan, Robert H Silverman, Srinivasan Dasarathy, Vinay Varadan, Daniel D De Carvalho, Abhishek A Chakraborty, Nima Sharifi
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (21) (2022)
Jeffrey M McManus, Benjamin Gaston, Joe Zein, Nima Sharifi
Association Between Asthma and Reduced Androgen Receptor Expression in Airways. Journal of the Endocrine Society 6 (5) (2022)
Jeffrey M McManus, Navin Sabharwal, Peter Bazeley, Nima Sharifi
Inheritance of a common androgen synthesis variant allele is associated with female COVID susceptibility in UK Biobank. European journal of endocrinology 187 (1) (2022)
Kunal Desai, Jeffrey M McManus, Nima Sharifi
Hormonal Therapy for Prostate Cancer. Endocrine reviews 42 (3) (2022)
Aimalie L Hardaway, Maryam Goudarzi, Michael Berk, Yoon-Mi Chung, Renliang Zhang, Jianneng Li, Eric Klein, Nima Sharifi
5-hydroxyeicosatetraenoic acid controls androgen reduction in diverse types of human epithelial cells. Endocrinology (2022)
Jeffrey M McManus, Roberto Vargas, Peter S Bazeley, Fredrick R Schumacher, Nima Sharifi
Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer. JNCI cancer spectrum 6 (5) (2022)
Sean T McSweeney, Hannah E Bergom, Anna Prizment, Susan Halabi, Nima Sharifi, Charles Ryan, Justin H Hwang
Regulatory genes in the androgen production, uptake and conversion (APUC) pathway in advanced prostate cancer. Endocrine oncology (Bristol, England) 2 (1) (2022)
Nima Sharifi
Kicking the dirt in the hunt for discoveries: pursuing a career in biomedical science. Nature reviews. Urology 18 (3) (2021)
Shelley Valle, Nima Sharifi
Targeting Glucocorticoid Metabolism in Prostate Cancer. Endocrinology 162 (9) (2021)
Jianneng Li, Michael Berk, Mohammad Alyamani, Navin Sabharwal, Christopher Goins, Joseph Alvarado, Mehdi Baratchian, Ziqi Zhu, Shaun Stauffer, Eric E Klein, Nima Sharifi
Hexose-6-phosphate dehydrogenase blockade reverses prostate cancer drug resistance in xenograft models by glucocorticoid inactivation. Science translational medicine 13 (595) (2021)
Joe Zein, Benjamin Gaston, Peter Bazeley, Mark D DeBoer, Robert P Igo, Eugene R Bleecker, Deborah Meyers, Suzy Comhair, Nadzeya V Marozkina, Calvin Cotton, Mona Patel, Mohammad Alyamani, Weiling Xu, William W Busse, William J Calhoun, Victor Ortega, Gregory A Hawkins, Mario Castro, Kian Fan Chung, John V Fahy, Anne M Fitzpatrick, Elliot Israel, Nizar N Jarjour, Bruce Levy, David T Mauger, Wendy C Moore, Patricia Noel, Stephen P Peters, W Gerald Teague, Sally E Wenzel, Serpil C Erzurum, Nima Sharifi
HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma. Proceedings of the National Academy of Sciences of the United States of America 117 (4) (2020)
C Alicia Traughber, Emmanuel Opoku, Gregory Brubaker, Jennifer Major, Hanxu Lu, Shuhui Wang Lorkowski, Chase Neumann, Aimalie Hardaway, Yoon-Mi Chung, Kailash Gulshan, Nima Sharifi, Jonathan Mark Brown, Jonathan D Smith
Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice. The Journal of biological chemistry 295 (24) (2020)
William S Chen, Eric L Feng, Rahul Aggarwal, Adam Foye, Tomasz M Beer, Joshi J Alumkal, Martin Gleave, Kim N Chi, Robert E Reiter, Matthew B Rettig, Christopher P Evans, Eric J Small, Nima Sharifi, Shuang G Zhao
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer. Prostate cancer and prostatic diseases 23 (2) (2019)
Jeffrey M McManus, Kelsey Bohn, Mohammad Alyamani, Yoon-Mi Chung, Eric A Klein, Nima Sharifi
Rapid and structure-specific cellular uptake of selected steroids. PloS one 14 (10) (2019)
Varadha Balaji Venkadakrishnan, Adam D DePriest, Sangeeta Kumari, Dhirodatta Senapati, Salma Ben-Salem, Yixue Su, Giridhar Mudduluru, Qiang Hu, Eduardo Cortes, Elena Pop, James L Mohler, Gissou Azabdaftari, Kristopher Attwood, Rajal B Shah, Christina Jamieson, Scott M Dehm, Cristina Magi-Galluzzi, Eric E Klein, Nima Sharifi, Song Liu, Hannelore V Heemers
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy. Oncogene 38 (23) (2019)
Jianneng Li, Mohammad Alyamani, Ao Zhang, Kai-Hsiung Chang, Michael Berk, Zhenfei Li, Ziqi Zhu, Marianne Petro, Cristina Magi-Galluzzi, Mary-Ellen Taplin, Jorge A Garcia, Kevin Courtney, Eric A Klein, Nima Sharifi
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer. eLife 6 (2017)